Grifols (GRFS) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Grifols, S.A. (GRFS) dominates the plasma niche due to inelastic demand and a global collection network. The business is currently undergoing a stabilization phase following an operational downturn, restoring its margins. The business valuation via EV/EBITDA visualizes this trend, where the indicator reaches 7.36. New management is focused on optimizing the structure and reducing debt to regain investor confidence.
grifols.com - analytical breakdowns and key metrics (GRFS)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
GRFS - Net Financial Result|Projected Future Earnings Grifols, S.A.|GRFS - Market Cap to Net Income|Future Price to Earnings Grifols, S.A.|GRFS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Grifols Biemat|GRFS - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Grifols|GRFS - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months grifols.com|GRFS - Earnings per share increase in current year|Net earnings per share growth forecast for next year Grifols, S.A.
Initial company analysis:Grifols Group GRFS
The global network of plasma collection centers and the diagnostic business of Grifols, S.A. (GRFS) stabilize margins, which is critical when analyzing a capital-intensive model. The current value of 7.36 reflects the ratio of total business value to operating profit before depreciation, allowing the EV/EBITDA dynamics to assess the company's debt sustainability and margin of safety amid high interest rates.
Main competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Pharvaris Pharma (PHVS)|abcellera.com (ABCL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|tourmalinebio.com - Business Value to Operating Income Before Depreciation|PGEN (Precigen) - EV/EBITDA Multiple|Pharming Group NV (PHAR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple NKTR|UPB: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Biopharma Inc ZBIO|immunome.com (IMNM) - Company Value to EBITDA|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KALV: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Septerna Corp (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SVRA|RIGL: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio (ANAB)|Total Company Value to Operating Income Before Depreciation Ratio Astria Therapeutics Inc|enGene Bio - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio rapt.com (RAPT)|Aerovate - EV/EBITDA Multiple|ACRS - EV/EBITDA Multiple|KYTX (Kyverna Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|CABA (Cabaletta Bio, Inc) - EV/EBITDA Multiple|VTYX - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|AVTX (avalotx.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|AGEN (Agenus, Inc.) - Company Value to Operating Income Before Depreciation Ratio|CLYM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio zurabio.com ZURA|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ADAG (Adagene Inc.)|IMA (ImageneBio) - EV/EBITDA Multiple|STTK: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple EQ|EV/EBITDA Multiple connectbiopharm.com (CNTB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|Business Value to Operating Income Before Depreciation ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio INMB|BRNS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to Operating Income Before Depreciation XTLB (XTL Bio)|EV/EBITDA Multiple BOLT|HCWB - Company Value to EBITDA|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Enterprise Value to EBITDA Multiple aimimmuno.com|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation GRI (GRI Bio Corporation)|XRTX: EV/EBITDA Multiple|HIND - Total Company Value to Operating Income Before Depreciation Ratio|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Indaptus Therapeutics Inc - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|CALI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|Allakos Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
